Kathleen A. Hilliard

Inflammatory cytokines in cystic fibrosis lungs.

Tracey L. Bonfield, James R. Panuska, Michael W. Konstan et al. · American Journal of Respiratory and Critical Care Medicine · 1995 · 704 citations

Inflammation, Inflammatory Cytokines, Fibrosis +11

Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.

Michael W. Konstan, Kathleen A. Hilliard, Tonya M. Norvell et al. · American Journal of Respiratory and Critical Care Medicine · 1994 · 515 citations

Asthma, Inflammatory Lung Disease, Lung Inflammation +18

Compacted DNA Nanoparticles Administered to the Nasal Mucosa of Cystic Fibrosis Subjects Are Safe and Demonstrate Partial to Complete Cystic Fibrosis Transmembrane Regulator Reconstitution

Michael W. Konstan, Pamela B. Davis, Jeffrey S. Wagener et al. · Human Gene Therapy · 2004 · 295 citations

Leukotriene B ₄ Markedly Elevated in the Epithelial Lining Fluid of Patients with Cystic Fibrosis

Michael W. Konstan, Ronald W. Walenga, Kathleen A. Hilliard et al. · American Review of Respiratory Disease · 1993 · 152 citations

A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis

Michael W. Konstan, Gerd Döring, Sonya L. Heltshe et al. · Journal of Cystic Fibrosis · 2014 · 133 citations · Full text

Ltb4 Receptor Antagonist, Inflammatory Lung Disease, Advanced Lung Disease +7